Kelvin C W Leung1, Robert R Quinn2,3, Pietro Ravani2,3, Henry Duff2,4, Jennifer M MacRae2,4. 1. Departments of Medicine, kelvin.leung@albertahealthservices.ca. 2. Departments of Medicine. 3. Community Health Sciences, and. 4. Cardiac Sciences, University of Calgary, Calgary, Alberta, Canada.
Abstract
BACKGROUND AND OBJECTIVES:Intradialytic hypotension (IDH) is associated with morbidity. The effect of blood volume-guided ultrafiltration biofeedback, which automatically adjusts fluid removal rate on the basis of blood volume parameters, on the reduction of IDH was tested in a randomized crossover trial. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We performed a 22-week, single blind, randomized crossover trial in patients receiving maintenance hemodialysis who had >30% of sessions complicated by symptomatic IDH in five centers in Calgary, Alberta, Canada. Participants underwent a 4-week run-in period to standardize dialysis prescription and dry weight on the basis of clinical examination. Those meeting inclusion criteria were randomized to best clinical practice hemodialysis (control) or best clinical practice plus blood volume-guided ultrafiltration biofeedback (intervention) for 8 weeks, followed by a 2-week washout and subsequent crossover for a second 8-week phase. The primary outcome was rate of symptomatic IDH. RESULTS:Thirty-five participants entered, 32 were randomized, and 26 completed the study. The rate of symptomatic IDH with biofeedback was 0.10/h (95% confidence interval, 0.06 to 0.14) and 0.07/h (95% confidence interval, 0.05 to 0.10) during control (P=0.29). There were no differences in the rate or proportion of sessions with asymptomatic IDH or symptoms alone. Results remained consistent when adjusted for randomization order and study week. There were no differences between intervention and control in the last study week in interdialytic weight gain (difference [SD], -0.02 [0.8] kg), brain natriuretic peptide (1460 [19,052] ng/L), cardiac troponins (3 [86] ng/L), extracellular water-to-intracellular water ratio (0.05 [0.33]), ultrafiltration rate (1.1 [7.0] ml/kg per hour), and dialysis recovery time (0.43 [19.25] hours). CONCLUSION: The use of blood volume monitoring-guided ultrafiltration biofeedback in patients prone to IDH did not reduce the rate of symptomatic IDH events.
RCT Entities:
BACKGROUND AND OBJECTIVES: Intradialytic hypotension (IDH) is associated with morbidity. The effect of blood volume-guided ultrafiltration biofeedback, which automatically adjusts fluid removal rate on the basis of blood volume parameters, on the reduction of IDH was tested in a randomized crossover trial. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We performed a 22-week, single blind, randomized crossover trial in patients receiving maintenance hemodialysis who had >30% of sessions complicated by symptomatic IDH in five centers in Calgary, Alberta, Canada. Participants underwent a 4-week run-in period to standardize dialysis prescription and dry weight on the basis of clinical examination. Those meeting inclusion criteria were randomized to best clinical practice hemodialysis (control) or best clinical practice plus blood volume-guided ultrafiltration biofeedback (intervention) for 8 weeks, followed by a 2-week washout and subsequent crossover for a second 8-week phase. The primary outcome was rate of symptomatic IDH. RESULTS: Thirty-five participants entered, 32 were randomized, and 26 completed the study. The rate of symptomatic IDH with biofeedback was 0.10/h (95% confidence interval, 0.06 to 0.14) and 0.07/h (95% confidence interval, 0.05 to 0.10) during control (P=0.29). There were no differences in the rate or proportion of sessions with asymptomatic IDH or symptoms alone. Results remained consistent when adjusted for randomization order and study week. There were no differences between intervention and control in the last study week in interdialytic weight gain (difference [SD], -0.02 [0.8] kg), brain natriuretic peptide (1460 [19,052] ng/L), cardiac troponins (3 [86] ng/L), extracellular water-to-intracellular water ratio (0.05 [0.33]), ultrafiltration rate (1.1 [7.0] ml/kg per hour), and dialysis recovery time (0.43 [19.25] hours). CONCLUSION: The use of blood volume monitoring-guided ultrafiltration biofeedback in patients prone to IDH did not reduce the rate of symptomatic IDH events.
Authors: Flavio M de Paula; Aldo J Peixoto; Luciano V Pinto; David Dorigo; Pedro J M Patricio; Sergio F F Santos Journal: Kidney Int Date: 2004-09 Impact factor: 10.612
Authors: I Ishida; H Hirakata; H Sugimori; T Omae; E Hirakata; S Ibayashi; M Kubo; M Fujishima Journal: Am J Kidney Dis Date: 1999-12 Impact factor: 8.860
Authors: J P de Vries; P M Kouw; N J van der Meer; C G Olthof; L P Oe; A J Donker; P M de Vries Journal: Kidney Int Date: 1993-10 Impact factor: 10.612
Authors: Gihad E Nesrallah; Rita S Suri; Heather Thiessen-Philbrook; Paul Heidenheim; Robert M Lindsay Journal: ASAIO J Date: 2008 May-Jun Impact factor: 2.872
Authors: Rammah Abohtyra; Yossi Chait; Michael J Germain; Christopher V Hollot; Joseph Horowitz Journal: IEEE Trans Biomed Eng Date: 2018-12-04 Impact factor: 4.538
Authors: Damien Ashby; Natalie Borman; James Burton; Richard Corbett; Andrew Davenport; Ken Farrington; Katey Flowers; James Fotheringham; R N Andrea Fox; Gail Franklin; Claire Gardiner; R N Martin Gerrish; Sharlene Greenwood; Daljit Hothi; Abdul Khares; Pelagia Koufaki; Jeremy Levy; Elizabeth Lindley; Jamie Macdonald; Bruno Mafrici; Andrew Mooney; James Tattersall; Kay Tyerman; Enric Villar; Martin Wilkie Journal: BMC Nephrol Date: 2019-10-17 Impact factor: 2.388
Authors: Indranil Dasgupta; G Neil Thomas; Joanne Clarke; Alice Sitch; James Martin; Brian Bieber; Manfred Hecking; Angelo Karaboyas; Ronald Pisoni; Friedrich Port; Bruce Robinson; Hugh Rayner Journal: Clin J Am Soc Nephrol Date: 2019-02-05 Impact factor: 8.237
Authors: Miguel Hueso; Alfredo Vellido; Nuria Montero; Carlo Barbieri; Rosa Ramos; Manuel Angoso; Josep Maria Cruzado; Anders Jonsson Journal: Kidney Dis (Basel) Date: 2018-01-25
Authors: Michael J Germain; Barbara A Greco; Spencer Hodgins; Bikash Chapagain; Ravi Thadhani; David Wojciechowski; Kerry Crisalli; Brian H Nathanson; Yossi Chait Journal: J Nephrol Date: 2021-05-24 Impact factor: 3.902
Authors: David F Keane; Jochen G Raimann; Hanjie Zhang; Joanna Willetts; Stephan Thijssen; Peter Kotanko Journal: Kidney Int Date: 2021-02-17 Impact factor: 10.612
Authors: Jennifer E Flythe; Matthew J Tugman; Julia H Narendra; Magdalene M Assimon; Quefeng Li; Yueting Wang; Steven M Brunelli; Alan L Hinderliter Journal: J Nephrol Date: 2020-09-25 Impact factor: 3.902